References
- Li Z, Ren D, Zhao Y, et al. Clinical characteristics and surgical outcome of thoracic myelopathy caused by ossification of the ligamentum flavum: a retrospective analysis of 85 cases. Spinal Cord 2016;54:188–96.
- Kang KC, Lee CS, Shin SK, et al. Ossification of the ligamentum flavum of the thoracic spine in the Korean population. J Neurosurg Spine 2011;14:513–19.
- Jia LS, Chen XS, Zhou SY, et al. En bloc resection of lamina and ossified ligamentum flavum in the treatment of thoracic ossification of the ligamentum flavum. Neurosurgery 2010;66:1181–6.
- Li F, Chen Q, Xu K. Surgical treatment of 40 patients with thoracic ossification of the ligamentum flavum. J Neurosurg Spine 2006;4:191–7.
- Zhong ZM, Wu Q, Meng TT, et al. Clinical outcomes after decompressive laminectomy for symptomatic ossification of ligamentum flavum at the thoracic spine. J Clin Neurosci 2016;28:77–81.
- Miyakoshi N, Shimada Y, Suzuki T, et al. Factors related to long-term outcome after decompressive surgery for ossification of the ligamentum flavum of the thoracic spine. J Neurosurg 2003;99:251–6.
- Maloney WF, Younge BR, Moyer NJ. Evaluation of the causes and accuracy of pharmacologic localization in Horner’s syndrome. Am J Ophthalmol 1980;90:394–402.
- Davagnanam I, Fraser CL, Miszkiel K, et al. Adult Horner’s syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond) 2013;27:291–8.
- Koc F, Kavuncu S, Kansu T, et al. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol 2005;89:1442–4.
- Morales J, Brown SM, Abdul-Rahim AS, et al. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol 2000;118:951–4.
- Danesh-Meyer HV, Savino P, Sergott R. The correlation of phenylephrine 1% with hydroxyamphetamine 1% in Horner's syndrome. Br J Ophthalmol 2004;88:592–3.
- Nagy AN, Hayman LA, Diaz-Marchan PJ, et al. Horner's syndrome due to first-order neuron lesions of the oculosympathetic pathway. AJR Am J Roentgenol 1997;169:581–4.